Antibodies against mutated citrullinated vimentin fail to predict anti-TNF treatment response in rheumatoid arthritis

被引：4
作者：
Dejaco, C. [1 ]
Duftner, C. [1 ]
Klotz, W. [2 ]
Schirmer, M. [1 ]
Herold, M. [2 ]
机构：
[1] Gen Hosp Elisabethinen, Dept Internal Med, A-9020 Klagenfurt, Austria
[2] Med Univ Innsbruck, Clin Div Gen Internal Med, Innsbruck, Austria
来源：
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY | 2009年 / 38卷 / 01期
关键词：
D O I：
10.1080/03009740802220067
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：66 / 67
页数：2
相关论文
共 10 条
[1]   Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study [J].
Atzeni, F ;
Sarzi-Puttini, P ;
Dell'Acqua, D ;
de Portu, S ;
Cecchini, G ;
Cruini, C ;
Carrabba, M ;
Meroni, PL .
ARTHRITIS RESEARCH & THERAPY, 2006, 8 (01)
[2]   Autoimmunity and anti-TNF-α agents [J].
Atzeni, F ;
Turiel, M ;
Capsoni, F ;
Doria, A ;
Meroni, P ;
Sarzi-Puttini, P .
AUTOIMMUNE DISEASES AND TREATMENT: ORGAN-SPECIFIC AND SYSTEMIC DISORDERS, 2005, 1051 :559-569
[3]   Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis [J].
Bang, Holger ;
Egerer, Karl ;
Gauliard, Anke ;
Luethke, Kirsten ;
Rudolph, Paul E. ;
Fredenhagen, Gert ;
Berg, Wigbert ;
Feist, Eugen ;
Burmester, Gerd-R. .
ARTHRITIS AND RHEUMATISM, 2007, 56 (08) :2503-2511
[4]   Predictive value of antibodies to citrullinated peptides and rheumatoid factors in anti-TNF-α treated patients [J].
Bobbio-Pallavicini, Francesca ;
Caporali, Roberto ;
Alpini, Claudia ;
Moratti, Remigio ;
Montecucco, Carlomaurizio .
AUTOIMMUNITY, PART A: BASIC PRINCIPLES AND NEW DIAGNOSTIC TOOLS, 2007, 1109 :287-295
[5]   High IgA rheumatoid factor levels are associated with poor clinical response to tumour necrosis factor a inhibitors in rheumatoid arthritis [J].
Bobbio-Pallavicini, Francesca ;
Caporali, Roberto ;
Alpini, Claudia ;
Avalle, Stefano ;
Epis, Oscar M. ;
Klersy, Catherine ;
Montecucco, Carlomaurizio .
ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (03) :302-307
[6]   Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis [J].
Dejaco, Christian ;
Klotz, Werner ;
Larcher, Heike ;
Duftner, Christina ;
Schirmer, Michael ;
Herold, Manfred .
ARTHRITIS RESEARCH & THERAPY, 2006, 8 (04)
[7]   Antibodies against citrullinated vimentin in rheumatoid arthritis [J].
Mathsson, Linda ;
Mullazehi, Mohammed ;
Wick, Marius C. ;
Sjoberg, Olof ;
van Vollenhoven, Ronald ;
Klareskog, Lars ;
Ronnelid, Johan .
ARTHRITIS AND RHEUMATISM, 2008, 58 (01) :36-45
[8]   Association of rheumatoid arthritis treatment response and disease duration with declines in serum levels of IgM rheumatoid factor and anti-cyclic citrullinated peptide antibody [J].
Mikuls, TR ;
O'Dell, JR ;
Stoner, JA ;
Parrish, LA ;
Arend, WP ;
Norris, JM ;
Holers, VM .
ARTHRITIS AND RHEUMATISM, 2004, 50 (12) :3776-3782
[9]   Autoantibodies to citrullinated antigens in (early) rheumatoid arthritis [J].
van Venrooij, Walther J. ;
Zendman, Albert J. W. ;
Pruijn, Ger J. M. .
AUTOIMMUNITY REVIEWS, 2006, 6 (01) :37-41
[10]   Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis - Comparison with the preliminary American College of Rheumatology and the World Health Organization International League Against Rheumatism criteria [J].
vanGestel, AM ;
Prevoo, MLL ;
vantHof, MA ;
vanRijswijk, MH ;
vandePutte, LBA ;
vanRiel, PLCM .
ARTHRITIS AND RHEUMATISM, 1996, 39 (01) :34-40
1